Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
February 2016—Primera Trio from Primera Technology is a small, lightweight, portable all-in-one printer. Designed for nurses and doctors to print on demand at hospitals and home care facilities, Primera Trio prints, copies, and scans in full color or black monochrome from a unit that weighs 2.6 pounds and is about the size of a hardcover book.
February 2016—Enzo Life Sciences now offers EQ Quencher Dyes—amine-reactive quencher dyes that can be used for fluorescence resonance energy transfer (FRET) applications.
February 2016—Hamilton Storage introduced RackWare HD138 and HD60 high-density SBS-footprint racks for microtube and cryovial storage. Designed for use with Hamilton’s BiOS, SAM, and Verso sample management and storage systems, RackWare increases storage capacity by increasing the number of tubes that can be placed in an SBS-footprint rack. The racks can also be used to maximize storage in manual freezers.
February 2016—MDxHealth announced that data demonstrating the clinical potential of its urine-based epigenetic bladder cancer test AssureMDx, to aid urologists in the management of patients presenting with hematuria, has been published in The Journal of Urology.
February 2016—Epic Sciences announced a collaboration with University of Pennsylvania’s Abramson Cancer Center on multiple studies to explore biomarkers, identified by analysis of circulating tumor cells at a single cell resolution, that are predictive of response to personalized cancer therapeutics.
February 2016—ScyTek Laboratories announced the availability of Pan Melanoma Cocktail antibody. This cocktail includes Tyrosinase, MART-1, and HMB45 clones.
February 2016—Biocartis launched two products on its molecular diagnostics platform Idylla. The first offering, the Idylla ctBRAF Mutation Assay, uses blood plasma as a sample. The assay can potentially act as a substitute for tissue biopsy testing in melanoma and colorectal and lung cancers, as well as conditions such as hairy cell leukemia and histiocytosis. It has a turnaround time of approximately 90 minutes with less than one minute of hands-on time.
February 2016—Roche launched the Ventana HE 600 system, its latest fully automated hematoxylin and eosin tissue staining system designed to enhance patient and technician safety and produce exceptional staining quality.
February 2016—BioTheranostics announced that it has closed a $32 million financing led by MVM Life Science Partners, with participation of Canepa Advanced Healthcare Fund and HealthQuest Capital. As a result of the financing, BioTheranostics will be spun out from BioMérieux, which will remain a minority shareholder, and operate as an independent company.
January 2016—Enzo Life Sciences launched a VEGF ELISA kit that provides a quantitative, competitive detection method for measuring melatonin in serum, plasma, and cell culture supernants.
